Dabur India
127 year old Dabur India, India’s 4th largest FMCG player and world’s largest ayurvedic and natural health care company, has a portfolio of master brands such as Dabur (ayurvedic healthcare), Vatika (premium hair care), Hajmola (digestives), Real (fruit juices and recently launched milkshakes) and Fem (fairness bleach and skin care). Dabur Honey enjoys market leadership with over 75% share in branded honey market while Dabur Chyawanprash is the largest selling Ayurvedic medicine with over 65% domestic market share.
Despite challenging macros, Q2FY14 financial performance was excellent, with consolidated revenues up 6% QoQ at Rs. 1,754 crore, thanks to whopping 26% growth in international business (accounting for 65% of topline) due to both favourable currency and volume growth. Middle East and Bangladesh regions are showing robust growth. On 6% topline growth, EBITDA jumped 30% sequentially to Rs. 352 crore, while net profit inched 34% higher QoQ to Rs. 250 crore. Q2 EPS stood at Rs. 1.43, leading the company to declare an interim dividend of Rs. 0.75 per share. Its H1FY14 consolidated revenues stood at Rs. 3,410 crore, with EBITDA of Rs. 623 crore. Net profit at Rs.436 crore was helped by expanding net margins to 12.8%, aided by easing material cost pressures on the international front. Net profit for first half of FY14 is Rs. 436 crore, leading to an EPS of Rs. 2.50. As of 30th September 2013, its networth stood at Rs.2,352 crore, with total debt of Rs. 1,062 crore, against cash and equivalents of Rs. 1,027 crore. Thus, the company can be termed as debt-free.